Simone Polvani Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

5/2022	Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression.
10/2020	Telomerase reactivation is associated with hepatobiliary and pancreatic cancers.
2/2016	Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
9/2014	Nuclear receptors and pathogenesis of pancreatic cancer.
4/2014	COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression.
2/2011	Acycloguanosyl 5'-thymidyltriphosphate, a thymidine analogue prodrug activated by telomerase, reduces pancreatic tumor growth in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simone Polvani Research Topics

Disease

11	Neoplasms (Cancer) 05/2022 - 01/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 02/2011
5	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 08/2010
3	Carcinogenesis 01/2023 - 08/2010
3	Adenocarcinoma 05/2022 - 04/2014
2	Insulin Resistance 01/2020 - 02/2016
2	Polyps 04/2017 - 10/2013
2	Inflammation (Inflammations) 02/2016 - 01/2012
2	Colorectal Neoplasms (Colorectal Cancer) 10/2013 - 01/2004
1	Hyponatremia 11/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021
1	Pancreatic Diseases (Pancreatic Disease) 10/2020
1	Cholangiocarcinoma 10/2020
1	Hyperthermia 04/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Necrotizing Enterocolitis 01/2017
1	Obesity 02/2016
1	Liver Neoplasms (Liver Cancer) 11/2014
1	Chromosomal Instability (Chromosome Stability) 09/2014
1	Colonic Polyps 10/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2013
1	Disease Progression 01/2009
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2009
1	Leukemia 08/2008
1	Neuroblastoma 08/2008
1	Adenoma (Adenomas) 01/2004
1	Colonic Neoplasms (Colon Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2022 - 01/2009
3	Transcription Factors (Transcription Factor)IBA 05/2022 - 08/2010
3	Orphan Nuclear ReceptorsIBA 05/2022 - 04/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 02/2011
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017 - 01/2009
2	Protein Isoforms (Isoforms)IBA 05/2022 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 09/2014
2	ThymidineIBA 11/2014 - 02/2011
2	ProdrugsIBA 11/2014 - 02/2011
2	Acyclovir (Aciclovir)FDA LinkGeneric 11/2014 - 02/2011
2	acycloguanosyl 5'-thymidyltriphosphateIBA 11/2014 - 02/2011
2	Ether (Diethyl Ether)IBA 10/2013 - 08/2008
2	Proteins (Proteins, Gene)FDA Link 08/2008 - 01/2004
2	Ion Channels (Ion Channel)IBA 08/2008 - 01/2004
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 11/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Long Noncoding RNAIBA 01/2022
1	Antidiuretic Hormone Receptor AntagonistsIBA 11/2021
1	Tolvaptan FDA Link 11/2021
1	Vasopressins (Vasopressin)IBA 11/2021
1	SodiumIBA 11/2021
1	EnzymesIBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2020
1	Formaldehyde (Formol)FDA Link 04/2017
1	DNA AdductsIBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	CarcinogensIBA 01/2017
1	SmokeIBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	AdiponectinIBA 02/2016
1	AdipokinesIBA 02/2016
1	Insulin (Novolin)FDA Link 02/2016
1	LeptinIBA 02/2016
1	Small Interfering RNA (siRNA)IBA 04/2014
1	MucinsIBA 10/2013
1	AzoxymethaneIBA 10/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2013
1	Gemcitabine FDA Link 02/2011
1	LigandsIBA 08/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 08/2010
1	ThiazolidinedionesIBA 08/2010
1	PPAR gammaIBA 08/2010

Therapy/Procedure

2	Therapeutics 04/2014 - 01/2004
1	Pancreaticoduodenectomy 12/2020
1	Drug Therapy (Chemotherapy) 07/2017
1	Surgical Instruments (Clip) 04/2017
1	Oral Administration 08/2010